Home > Annual Financials > LUPIN

LUPIN Financial Statement Analysis
[BOM: 500257|NSE : LUPIN]

The Revenues of LUPIN have increased by 13.48% YoY .
The Earnings Per Share (EPS) of LUPIN has increased by 62.29 % YoY.
COMMUNITY POLL
for LUPIN
Please provide your vote to see the results

LUPIN Last 5 Annual Financial Results
[BOM: 500257|NSE : LUPIN]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹22,708 Cr₹20,011 Cr₹16,642 Cr₹16,405 Cr₹15,163 Cr
Expenses ₹17,430 Cr₹16,222 Cr₹14,921 Cr₹16,190 Cr₹12,596 Cr
Operating Profit (Excl OI) ₹5,278 Cr₹3,789 Cr₹1,721 Cr₹215 Cr₹2,567 Cr
Other Income ₹202 Cr₹142 Cr₹151 Cr₹214 Cr₹136 Cr
Interest ₹295 Cr₹312 Cr₹274 Cr₹143 Cr₹141 Cr
Depreciation ₹1,169 Cr₹1,197 Cr₹881 Cr₹1,659 Cr₹887 Cr
Profit Before Tax ₹4,015 Cr₹2,422 Cr₹716 Cr₹-1,372 Cr₹1,676 Cr
Profit After Tax ₹3,306 Cr₹1,936 Cr₹448 Cr₹-1,509 Cr₹1,228 Cr
Consolidated Net Profit ₹3,282 Cr₹1,914 Cr₹430 Cr₹-1,528 Cr₹1,217 Cr
Earnings Per Share (Rs)₹116.64₹71.87₹42.01₹9.45₹-33.62
PAT Margin (%)12.428.896.101.57-5.09
ROE(%)27.1121.1314.613.68-11.79
ROCE(%)28.8621.9716.246.06-7.11
Total Debt/Equity(x)0.260.300.190.340.32

Key Financials

Market Cap : ₹ 90,040.1 Cr
Revenue (TTM) : ₹ 30,746.3 Cr
Net Profit(TTM) : ₹ 5,221.5 Cr
EPS (TTM) : ₹ 114.2
P/E (TTM) : 17.2

Industry Peers & Returns1W1M1Y
LUPIN -2.2% 0.8% -4.8%
SUN PHARMACEUTICAL INDUSTRIES -0.8% 7.3% 7.7%
DIVIS LABORATORIES -3.3% 21.8% 68.7%
TORRENT PHARMACEUTICALS -1.7% 1.9% 22.1%
CIPLA 0.7% 6.7% -9.4%
DR REDDYS LABORATORIES 0.7% 12.4% 12.4%
MANKIND PHARMA 0.2% 17.2% 15.5%
ZYDUS LIFESCIENCES -0.9% 7.4% 27.4%
AUROBINDO PHARMA -0.2% 11.5% 48.3%


LUPIN Revenues
[BOM: 500257|NSE : LUPIN]

Y-o-Y

13.48 %

5 Yr CAGR

10.62 %

Years Revenues % Change
Mar2026 ₹22,708 Cr
13.48
Mar2025 ₹20,011 Cr
20.25
Mar2024 ₹16,642 Cr
1.44
Mar2023 ₹16,405 Cr
8.19
Mar2022 ₹15,163 Cr -


LUPIN Operating Profit
[BOM: 500257|NSE : LUPIN]

Y-o-Y

39.28 %

5 Yr CAGR

19.74 %

Years Operating Profit % Change
Mar2026 ₹5,278 Cr
39.28
Mar2025 ₹3,789 Cr
120.22
Mar2024 ₹1,721 Cr
699.37
Mar2023 ₹215 Cr
-91.61
Mar2022 ₹2,567 Cr -

Operating Margins
Y-o-Y

22.70 %

5 Yr CAGR

8.24 %

Years Operating Margin% % Change
Mar2026 23.24%
22.70
Mar2025 18.94%
83.17
Mar2024 10.34%
689.31
Mar2023 1.31%
-92.26
Mar2022 16.93% -

LUPIN Profit After Tax
[BOM: 500257|NSE : LUPIN]

Y-o-Y

71.41 %

5 Yr CAGR

28.16 %

Years Profit After Tax % Change
Mar2026 ₹3,282 Cr
71.41
Mar2025 ₹1,914 Cr
345.15
Mar2024 ₹430 Cr
Positive
Mar2023 ₹-1,528 Cr
Negative
Mar2022 ₹1,217 Cr -

PAT Margins
Y-o-Y

39.71 %

5 Yr CAGR

Positive

Years PAT Margin(%) % Change
Mar2026 12.42 %
39.71
Mar2025 8.89 %
45.74
Mar2024 6.1 %
288.54
Mar2023 1.57 %
Positive
Mar2022 -5.09 % -

LUPIN Earnings Per Share (EPS)
[BOM: 500257|NSE : LUPIN]

Y-o-Y

62.29 %

5 Yr CAGR

Positive

Years EPS % Change
Mar2026 ₹117
62.29
Mar2025 ₹72
71.08
Mar2024 ₹42
344.55
Mar2023 ₹9.45
Positive
Mar2022 ₹-34 -

LUPIN Return on Capital Employed (ROCE)
[BOM: 500257|NSE : LUPIN]

Y-o-Y

31.36 %

5 Yr CAGR

Positive

Years ROCE % Change
Mar2026 28.86%
31.36
Mar2025 21.97%
35.28
Mar2024 16.24%
167.99
Mar2023 6.06%
Positive
Mar2022 -7.11% -

LUPIN Share Price vs Sensex

Current Share Price : ₹1,969.0
Current MarketCap: ₹ 90,040.1 Cr
Updated EOD on :Nov 18,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
LUPIN

-2.2%

0.8%

-4.8%

SENSEX

0.2%

9.8%

-2.9%

LUPIN related INDICES

BSE Indices1W1M1Y
BSE 100 ESG INDEX -0.3% 8.2% -2.1%
BSE 100 -0.3% 7.9% -1.7%
BSE INDIA 150 INDEX -0.4% 7.4% -0.8%
BSE 200 -0.4% 7.1% -1.5%
BSE 250 LARGEMIDCAP INDEX -0.5% 7% -1.2%
NSE Indices1W1M1Y
NIFTY 200 -0.6% 7.1% -1.3%
NIFTY 500 -0.6% 6.1% -0.9%
NIFTY HEALTHCARE INDEX -0.6% 10% 16.7%
NIFTY500 HEALTHCARE INDEX -0.7% 10.1% 18.2%
NIFTY500 MULTICAP 50:25:25 -0.7% 4.9% 0.3%

You may also like the below Video Courses


FAQ about LUPIN Financials


How the annual revenues of LUPIN have changed ?

The Revenues of LUPIN have increased by 13.48% YoY .

How the Earnings per Share (EPS) of LUPIN have changed?

The Earnings Per Share (EPS) of LUPIN has increased by 62.29 % YoY .